Your browser doesn't support javascript.
loading
Ifosfamide and etoposide in advanced-stage, relapsed or refractory primary cutaneous T-cell lymphomas.
Dangien, A; Ram-Wolff, C; Brice, P; Battistella, M; Roelens, M; Moins-Teisserenc, H; Peffault de Latour, R; Mourah, S; Bouaziz, J-D; Lebbé, C; Bagot, M; de Masson, A.
  • Dangien A; Dermatology, Saint-Louis Hospital, AP-HP, Paris, France.
  • Ram-Wolff C; Dermatology, Saint-Louis Hospital, AP-HP, Paris, France.
  • Brice P; Department of, Hematology, Saint-Louis Hospital, AP-HP, Paris, France.
  • Battistella M; Department of, Pathology, Saint-Louis Hospital, AP-HP, Paris, France.
  • Roelens M; INSERM U976 Human Immunology, Pathophysiology and Immunotherapy, Paris, France.
  • Moins-Teisserenc H; Université de Paris, Paris, France.
  • Peffault de Latour R; Université de Paris, Paris, France.
  • Mourah S; INSERM U1160, Paris, France.
  • Bouaziz JD; Université de Paris, Paris, France.
  • Lebbé C; INSERM U1160, Paris, France.
  • Bagot M; Department of, Hematology and Bone Marrow Transplant, Saint-Louis Hospital, AP-HP, Paris, France.
  • de Masson A; Université de Paris, Paris, France.
Br J Dermatol ; 183(5): 961-962, 2020 11.
Article en En | MEDLINE | ID: mdl-32407544

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Linfoma no Hodgkin / Linfoma Cutáneo de Células T Límite: Humans Idioma: En Año: 2020 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Linfoma no Hodgkin / Linfoma Cutáneo de Células T Límite: Humans Idioma: En Año: 2020 Tipo del documento: Article